E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor
暂无分享,去创建一个
R. Linhardt | J. Dordick | Fuming Zhang | Weihong Zhong | Mellisa Ly | A. Hickey | Zhenyu Wang | A. Suen | Fuming Zhang
[1] R. Linhardt,et al. Analysis of E. coli K5 capsular polysaccharide heparosan , 2011, Analytical and bioanalytical chemistry.
[2] Zhenqing Zhang,et al. Nuclear magnetic resonance quantification for monitoring heparosan K5 capsular polysaccharide production. , 2010, Analytical biochemistry.
[3] S. Bhattacharyya,et al. Cell-bound IL-8 increases in bronchial epithelial cells after arylsulfatase B silencing due to sequestration with chondroitin-4-sulfate. , 2010, American journal of respiratory cell and molecular biology.
[4] R. Linhardt,et al. Recent progress and applications in glycosaminoglycan and heparin research. , 2009, Current opinion in chemical biology.
[5] R. Langer,et al. Orthogonal analytical approaches to detect potential contaminants in heparin , 2009, Proceedings of the National Academy of Sciences.
[6] Zhenqing Zhang,et al. Structural Snapshots of Heparin Depolymerization by Heparin Lyase I* , 2009, The Journal of Biological Chemistry.
[7] Haiying Liu,et al. Lessons learned from the contamination of heparin. , 2009, Natural product reports.
[8] M. Goldrick,et al. The Escherichia coli K5 Capsule Is Not Synthesized in a Protected Compartment within the Cytoplasm , 2008, Journal of bacteriology.
[9] Jesús Jiménez-Barbero,et al. Solution structures of chemoenzymatically synthesized heparin and its precursors. , 2008, Journal of the American Chemical Society.
[10] R. Langer,et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. , 2008, The New England journal of medicine.
[11] Robert Langer,et al. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events , 2008, Nature Biotechnology.
[12] I. Roberts,et al. The cell surface expression of group 2 capsular polysaccharides in Escherichia coli: the role of KpsD, RhsA and a multi‐protein complex at the pole of the cell , 2006, Molecular microbiology.
[13] Joseph Shiloach,et al. Growing E. coli to high cell density--a historical perspective on method development. , 2005, Biotechnology advances.
[14] M. Salmivirta,et al. Generation of "neoheparin" from E. coli K5 capsular polysaccharide. , 2005, Journal of medicinal chemistry.
[15] R. Linhardt,et al. Role of glycosaminoglycans in cellular communication. , 2004, Accounts of chemical research.
[16] M. Manzoni,et al. Influence of the culture conditions on extracellular lyase activity related to K5 polysaccharide , 2004, Biotechnology Letters.
[17] Michael J Cooney,et al. Tracking the acetate threshold using DO‐transient control during medium and high cell density cultivation of recombinant Escherichia coli in complex media , 2003, Biotechnology and bioengineering.
[18] R. Linhardt. 2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity. , 2003, Journal of medicinal chemistry.
[19] C. White,et al. Identification and Molecular Cloning of a Heparosan Synthase fromPasteurella multocida Type D* , 2002, The Journal of Biological Chemistry.
[20] W. Johnston,et al. Industrial control of recombinant E. coli fed-batch culture: new perspectives on traditional controlled variables , 2002, Bioprocess and biosystems engineering.
[21] S. Olson,et al. Heparin Enhances the Specificity of Antithrombin for Thrombin and Factor Xa Independent of the Reactive Center Loop Sequence , 2001, The Journal of Biological Chemistry.
[22] R. P. Silver,et al. ABC transporters and the export of capsular polysaccharides from gram-negative bacteria. , 2001, Research in microbiology.
[23] C. Arrecubieta,et al. The Transport of Group 2 Capsular Polysaccharides across the Periplasmic Space in Escherichia coli , 2001, The Journal of Biological Chemistry.
[24] N. Cook,et al. Identification that KfiA, a protein essential for the biosynthesis of the Escherichia coli K5 capsular polysaccharide, is an alpha -UDP-GlcNAc glycosyltransferase. The formation of a membrane-associated K5 biosynthetic complex requires KfiA, KfiB, and KfiC. , 2000, The Journal of biological chemistry.
[25] I. Roberts,et al. Regulation of the Escherichia coli K5 Capsule Gene Cluster: Evidence for the Roles of H-NS, BipA, and Integration Host Factor in Regulation of Group 2 Capsule Gene Clusters in Pathogenic E. coli , 2000, Journal of bacteriology.
[26] I S Roberts,et al. Structure, assembly and regulation of expression of capsules in Escherichia coli , 1999, Molecular microbiology.
[27] L. Kjellén,et al. Regulated Diversity of Heparan Sulfate* , 1998, The Journal of Biological Chemistry.
[28] S. Lee,et al. High cell density culture of metabolically engineered Escherichia coli for the production of poly(3-hydroxybutyrate) in a defined medium. , 1998, Biotechnology and bioengineering.
[29] M. Kaghad,et al. N-acetyl-heparosan lyase of Escherichia coli K5: gene cloning and expression , 1996, Journal of bacteriology.
[30] M. Manzoni,et al. Production of K5 Polysaccharides of Different Molecular Weight by Escherichia Coli , 1996 .
[31] A. Shashkov,et al. Analysis of the enzymatic cleavage (beta elimination) of the capsular K5 polysaccharide of Escherichia coli by the K5-specific coliphage: reexamination , 1996, Journal of bacteriology.
[32] E. Vimr,et al. Thermoregulation of kpsF, the first region 1 gene in the kps locus for polysialic acid biosynthesis in Escherichia coli K1 , 1996, Journal of bacteriology.
[33] S. Lee,et al. High cell-density culture of Escherichia coli. , 1996, Trends in biotechnology.
[34] U. Rinas,et al. Simple fed-batch technique for high cell density cultivation of Escherichia coli. , 1995, Journal of biotechnology.
[35] M. Manzoni,et al. Extracellular K5 Polysaccharide of Escherichia coli: Production and Characterization , 1993 .
[36] A. Finke,et al. Biosynthesis of the Escherichia coli K5 polysaccharide, a representative of group II capsular polysaccharides: polymerization in vitro and characterization of the product , 1991, Journal of bacteriology.
[37] K. Jann,et al. Structure and biosynthesis of the capsular antigens of Escherichia coli. , 1990, Current topics in microbiology and immunology.
[38] K. Yoshida,et al. Analysis of unsaturated disaccharides from glycosaminoglycuronan by high-performance liquid chromatography. , 1989, Analytical biochemistry.
[39] C. Cooney,et al. Polysaccharide lyases , 1986, Applied biochemistry and biotechnology.
[40] M. Schmidt,et al. Phospholipid substitution of capsular (K) polysaccharide antigens from Escherichia coli causing extraintestinal infections , 1982 .
[41] M. Schmidt,et al. The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. , 1981, European journal of biochemistry.
[42] M. Schmidt,et al. The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. , 1981, European journal of biochemistry.
[43] T BITTER,et al. A modified uronic acid carbazole reaction. , 1962, Analytical biochemistry.
[44] R. Linhardt. Heparin : Structure and Activity , 2022 .